Literature DB >> 31460782

Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.

Shanshan Liu1,2, Wenjuan Tian1,2, Burong Li1.   

Abstract

The purpose of this study is to explore the function and regulatory networks of differentially expressed genes (DEGs) in head and neck squamous cell carcinoma (HNSC) by bioinformatics analysis using bioinformatics methods. The gene expression profile associated with HNSC was upregulated from the Cancer RNA-Seq Nexus (CRN) database and Oncomine. Functional analysis of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and gene ontology was performed on DEGs. The protein-protein interaction (PPI) network of DEGs was constructed using STRING and Cytoscape databases. A PPI network contained 101 genes. According to the comprehensive analysis of Degree and MCODE score, there are 12 genes. Based on the screened protein network and differential genes, further exploration was conducted according to The Cancer Genome Atlas (TCGA) normal and the genotype-tissue expression (GTEx) data. This investigation involved observing the expression of the first eight hub genes in tissues and the expression of NIMA-related kinase 2 (NEK2) in different stages and then survival analysis of HNSC. Results showed that NEK2 has important value in HNSC, which provides a reference for the molecular mechanism of HNSC.

Entities:  

Keywords:  DEGs; NEK2; bioinformatics analysis; head and neck squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31460782     DOI: 10.1089/cmb.2019.0208

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  3 in total

1.  Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer.

Authors:  Qiuli Chen; Hui Li; Lichao Yang; Sha Wen; Xuejing Huang; Jiajuan Liu; Xiaoping Guo; Bing Hu; Gang Li; Min He
Journal:  BMC Biotechnol       Date:  2021-10-27       Impact factor: 2.563

Review 2.  Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies.

Authors:  Araceli Diez-Fraile; Joke De Ceulaer; Charlotte Derpoorter; Christophe Spaas; Tom De Backer; Philippe Lamoral; Johan Abeloos; Tim Lammens
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

3.  An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors:  Dayang Chen; Mengmeng Wang; Ying Guo; Wei Wu; Xiang Ji; Xiaowen Dou; Huamei Tang; Zengyan Zong; Xiuming Zhang; Dan Xiong
Journal:  Cancer Med       Date:  2021-07-27       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.